"idoctor"

Purpose: This study aimed to evaluate the risk of proliferative diabetic retinopathy (DR) in the fellow eye of an eye with existing proliferative DR.Methods: Our DR screening programme database listed 1513 diabetes patients alive at the time of the study. Seventy-six had proliferative DR in one or both eyes.Results: In 28 of the 76 (37%) diabetes patients, proliferative DR was diagnosed in both eyes at the same examination. Another 28 patients developed proliferative DR in the second eye within 5 years of its diagnosis in the first eye, bringing the total number of diabetes patients with proliferative DR in both eyes at 5 years to 56 (74%). Almost all the diabetes patients eventually developed proliferative DR in the second eye. The median duration of diabetes before the development of proliferative retinopathy was 19 years for type 1 and 14 years for type 2 diabetes.Conclusions: Proliferative DR is a bilateral disease. Diabetes patients with proliferative DR in one eye are at high risk of developing neovascularization in the second eye and close follow-up is recommended.

Similar Posts:

• Associations between chronic glycosylated haemoglobin (HbA1c) level and macular volume in diabetes patients without macular oedema
• Prophylactic laser treatment of soft drusen maculopathy: a prospective, randomized Nordic study
• Diabetic macular oedema and visual loss: relationship to location, severity and duration
• Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
• Vitrectomy may prevent the occurrence of diabetic macular oedema
• Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes
• Cataract surgery in a population-based cohort of patients with type 1 diabetes: long-term incidence and risk factors
• The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results
• The North Jutland County Diabetic Retinopathy Study (NCDRS)
• Visual outcomes 12 months after phacoemulsification cataract surgery in patients with diabetes

Share/Save

This entry was posted on Thursday, July 16th, 2009 at 3:16 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.